Bgm BGM
NASDAQ BGM
$0.26 -0.02 (-7.14%)
At close: Aug 20, 2026 · 4:00 PM EDT

Bgm (BGM) Operating Leases (2020 - 2025)

Bgm (BGM) posted quarterly Operating Leases of $79311.0 for Q3 2025, down 71.47% year-over-year from $278012.0 in Q3 2024, and down 22.1% quarter-over-quarter from $101814.0 in Q1 2025.

Bgm (BGM) Operating Leases (2020 - 2025) Analysis & Trends

Bgm (BGM) has reported Operating Leases for 6 consecutive years, with $79311.0 the latest figure, recorded in Q3 2025.

  • In Q3 2025, Operating Leases fell 71.47% year-over-year to $79311.0; the TTM figure through Sep 2025 stood at $79311.0 (down 71.47% YoY), while the FY2025 annual figure was $79311.0, down 71.47% from the prior year.
  • Operating Leases fell to $79311.0 in Q3 2025 per BGM's latest filing, from $101814.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $79.1 billion in Q1 2022 and bottomed at $17667.0 in Q1 2024.
  • Historically, Operating Leases has averaged $14.1 billion across 5 years, with a median of $101814.0 in 2025.
  • On a YoY basis, Operating Leases climbed as much as 1031.28% in 2024 and fell as far as 100.0% in 2024.
  • Bgm's Operating Leases stood at $106180.0 in 2021, then sank by 31.68% to $72537.0 in 2022, then tumbled by 66.12% to $24575.0 in 2023, then jumped by 1031.28% to $278012.0 in 2024, then plunged by 71.47% to $79311.0 in 2025.
  • Business Quant data shows BGM's Operating Leases at $79311.0 in Q3 2025, $101814.0 in Q1 2025, and $278012.0 in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.83 Bn 42.86 Bn -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn -
10 Bgm 30.61 Mn 20.79 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 79,311.00
Mar 31, 2025 101,814.00
Sep 30, 2024 278,012.00
Mar 31, 2024 17,667.00
Sep 30, 2023 24,575.00
Mar 31, 2023 47.70 Bn
Sep 30, 2022 72,537.00
Mar 31, 2022 79.15 Bn
Sep 30, 2021 106,180.00
Sep 30, 2020 155,723.00